Skip to content

Comparison of transvaginal natural orifice transluminal laparoscopic high sacral ligament fixation and traditional transvaginal uterosacral ligament suspension: a randomized controlled study

Comparison of transvaginal natural orifice transluminal laparoscopic high sacral ligament fixation and traditional transvaginal uterosacral ligament suspension

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051932
Enrollment
Unknown
Registered
2021-10-09
Start date
2021-10-15
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic organ prolapse

Interventions

experimental group:transvaginal natural orifice transluminal laparoscopic high sacral ligament fixation
control group:traditional transvaginal uterosacral ligament suspension

Sponsors

The Third Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.According to the POP Quantification system (POP-Q), patients who were confirmed that the uterine or vaginal top prolapse >= II degree, or the anterior vaginal wall prolapse >= II degree combined with the uterine or vagina top prolapse >= II degree, and has completed the childbirth; 2.Sexual life history; 3.Sign written consent form.

Exclusion criteria

Exclusion criteria: 1.History of rectal surgery, suspected rectovaginal septum endometriosis or tumor; 2.History of pelvic inflammatory disease; 3.Acute infection of the lower genital tract; 4.Pregnant.

Design outcomes

Primary

MeasureTime frame
completion rate;

Secondary

MeasureTime frame
visual analogue scale was used to evaluate pain at postoperative day 1 to 7;operation time;postoperative hospital stay;pelvic organ prolapse was scored by quantitative staging before surgery and at 6 weeks, 3 months and 1 year after surgery;intraoperative and postoperative complications 6 weeks, 3 months and 1 year;pelvic floor dysfunction questionnaire (PFIQ-7) and urinary incontinence questionnaire before and after surgery at 6 weeks, 3 months and 1 year;intraoperative blood loss;

Countries

China

Contacts

Public ContactLin Qiongyan

The Third Affiliated Hospital of Guangzhou Medical University

172752288@qq.com+86 13580497536

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026